Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to biomedical research
Early-bird member-only registration for the 57th ASH Annual Meeting is now open.
The abstract submission site is now open for the 57th ASH Annual Meeting. The deadline to submit abstracts is August 4, 2015, 11:59 p.m. (PDT).
Advance registration is now open. Hear top experts in hematologic malignancies discuss the latest developments in clinical care.
Urge Congress to find a balanced approach to deficit reduction that does not involve further cuts to medical research.
Search a database of practicing hematologists in your area.
Help move hematology forward by supporting research, career development, and quality care and education programs.
Become part of a global network of more than 16,000 hematologists working to conquer blood diseases.
The American Society of Hematology (ASH) today announced the names of 13 medical students selected to participate in the 2015 Minority Medical Student Award Program (MMSAP).
The American Society of Hematology (ASH) today announced the names of 10 medical students and 18 residents selected to receive a 2015 ASH HONORS Award.
The American Society of Hematology (ASH) today announced the names of seven outstanding fellows selected to receive a 2015 ASH Research Training Award for Fellows (RTAF). Support from this grant is designed to encourage fellows in hematology, hematology/oncology, or other hematology-related training programs to pursue a career in academic hematology by providing them with protected time to conduct research during their training.
The American Society of Hematology (ASH) will honor Alfred Goldberg, PhD, of Harvard Medical School and Paul Richardson, MD, of Dana-Farber Cancer Institute, with the 2015 Ernest Beutler Lecture and Prize for their significant research advances in the area of proteasome inhibitors and their development as novel therapies for multiple myeloma.
On July 8, 2015, the Centers for Medicare and Medicaid Services (CMS) released its
governing payments for physician services and other associated policies covering the calendar year of 2016. This is the first physician fee schedule proposed rule following
the passage of the Medicare Access and CHIP Reauthorization Act (MACRA), which eliminated the sustainable growth rate formula that had long mandated cuts each year. Please follow the link above to learn more.
Guaranteeing access to clinical trials for cancer patients has long been a priority for ASH. Recently, the Departments of Health and Human Services and Labor (which are both responsible for implementing the various provisions of the health reform law)
there would not be federal regulations to implement the clinical trials coverage provision of the health reform law. The agencies determined the statutory language was self-implementing, and indicated that the Departments do not expect to issue regulations in the near future. Please follow the link above to learn more about this issue.
The Centers for Medicare and Medicaid Services (CMS) has announced a new plan that will introduce some leniency in the introduction of the new ICD-10 diagnosis coding system. Most notably, claims will not be rejected if the diagnosis coding is not to the correct level of specificity. To see an example from the field of hematology, please follow the link. ASH staff has prepared a full article giving an example of the diagnosis coding for lymphoid leukemia.
In the first weekend of June in Chicago, representatives from medical specialty societies and state medical societies convened a meeting of the semi-annual American Medical Association (AMA)
House of Delegates. The House of Delegates is composed of more than 500 physician representatives, and they consider resolutions covering a wide gamut of issues, such as health information technology, maintenance of certification, and menu labeling for food allergies. ASH was represented at the meeting this year. Follow the link to read more.
Dr. Rajkumar discusses how Dr. Robert Kyle started and developed the Multiple Myeloma Program at the Mayo Clinic. Dr. Kyle reflects on the success of the program for over 50 years.
Drs. Gale, Bennett, and Hoffman discuss factors hematologists must keep in mind when diagnosing patients with therapy-related AML or MDS, in order to prevent incorrect therapy decisions.
Drs. Badawy, Liem, and Thompson discuss several benefits, risks, and limitations of using health-related apps, focusing on hematology and oncology apps. They present a thorough study that includes recommendations of some of the best apps available, and a discussion of clinical benefits, cost-effectiveness, potential risks, and even legal concerns.
Dr. Dhawale evaluates the environment that fellows in training will encounter once they enter the workforce, and provides some resources to help with this transition.
AMERICAN SOCIETY OF HEMATOLOGY
2021 L Street NW, Suite 900, Washington, DC 20036
Phone 202-776-0544 | Fax 202-776-0545
by American Society of Hematology